New IHE Report on patient pathways in the treatment of opioid drug dependency6 Mar 2020
In this report, the Swedish Institute for Health Economics analyses…
New IHE publication reviews the use of risk sharing agreements in Sweden4 Mar 2020
In 2014 managed entry agreements (MEA) between Swedish health care…
New IHE publication shows that cancer causes costs of €199 billion in Europe4 Mar 2020
A new IHE publication in the European Journal of Cancer…
Doctoral thesis2 Mar 2020
Sara Olofsson, research manager at IHE, presented her dissertation ‘The…
EU launch event of IHE’s Comparator report on cancer24 Jan 2020
Next week (29 January) Thomas Hofmarcher will present the main…
Staff News17 Jan 2020
The Swedish Institute for Health Economics welcomes George Keel and…
New IHE Comparator Report on cancer in Europe16 Jan 2020
In a new report, IHE analyzes and compares the cancer…
Health-economic modelling without direct cardioprotective effects substantially underestimates the benefits of new classes of diabetes drugs5 Nov 2019
People with type 2 diabetes mellitus (T2DM) have an increased…
Risk Factor Clustering and the Economic Modeling of T2DM5 Nov 2019
Microsimulation using risk equations to convert biomarker values into event…
IHE participates at ISPOR in Copenhagen24 Oct 2019
IHE participates at the ISPOR (International Society for Pharmaeconomics and…